tradingkey.logo

SI-BONE Inc

SIBN
查看详细走势图
20.360USD
0.000
收盘 12/26, 16:00美东报价延迟15分钟
881.05M总市值
亏损市盈率 TTM

SI-BONE Inc

20.360
0.000
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

0.00%

5天

-0.10%

1月

+4.52%

6月

+10.47%

今年开始到现在

+45.22%

1年

+48.40%

查看详细走势图

TradingKey SI-BONE Inc股票评分

单位: USD 更新时间: 2025-12-26

操作建议

SI-BONE Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名41/207位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价25.22。中期看,股价处于上升通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

SI-BONE Inc评分

相关信息

行业排名
41 / 207
全市场排名
132 / 4563
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 9 位分析师
买入
评级
25.222
目标均价
+32.75%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

SI-BONE Inc亮点

亮点风险
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
业绩高增长
公司营业收入稳步增长,连续3年增长57.11%
估值低估
公司最新PE估值-39.94,处于3年历史低位
机构减仓
最新机构持股41.74M股,环比减少8.47%
PRFDX持仓
明星投资者PRFDX持仓,最新持仓市值3.74K

SI-BONE Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

SI-BONE Inc简介

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
公司代码SIBN
公司SI-BONE Inc
CEOFrancis (Laura A)
网址https://si-bone.com/

常见问题

SI-BONE Inc(SIBN)的当前股价是多少?

SI-BONE Inc(SIBN)的当前股价是 20.360。

SI-BONE Inc的股票代码是什么?

SI-BONE Inc的股票代码是SIBN。

SI-BONE Inc股票的52周最高点是多少?

SI-BONE Inc股票的52周最高点是21.070。

SI-BONE Inc股票的52周最低点是多少?

SI-BONE Inc股票的52周最低点是12.495。

SI-BONE Inc的市值是多少?

SI-BONE Inc的市值是881.05M。

SI-BONE Inc的净利润是多少?

SI-BONE Inc的净利润为-30.91M。

现在SI-BONE Inc(SIBN)的股票是买入、持有还是卖出?

根据分析师评级,SI-BONE Inc(SIBN)的总体评级为买入,目标价格为25.222。

SI-BONE Inc(SIBN)股票的每股收益(EPS TTM)是多少

SI-BONE Inc(SIBN)股票的每股收益(EPS TTM)是-0.510。
KeyAI